Literature DB >> 16501881

Sildenafil in pulmonary hypertension secondary to unilateral agenesis of pulmonary artery.

M A Hamdan1, R M Abu-Sulaiman, H K Najm.   

Abstract

Unilateral agenesis of the pulmonary artery (PA) is a rare anomaly that can lead to pulmonary hypertension (PHTN). We report the case of a 10-month-old female with agenesis of the left PA, ventricular septal defect, and patent ductus arteriosus who developed PHTN precluding surgical repair. The use of sildenafil decreased PA pressure and normalized pulmonary vascular resistance, after which surgery was successfully performed.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16501881     DOI： 10.1007/s00246-005-1100-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  10 in total

1.  Chronic oral sildenafil therapy in severe pulmonary artery hypertension.

Authors:  Shyam S Kothari; Bhanu Duggal
Journal:  Indian Heart J       Date:  2002 Jul-Aug

2.  Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension.

Authors:  D Abrams; I Schulze-Neick; A G Magee
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

3.  Absent or occult pulmonary artery.

Authors:  P Presbitero; C Bull; S G Haworth; M R de Leval
Journal:  Br Heart J       Date:  1984-08

4.  Absent pulmonary artery. A hint to its embryogenesis.

Authors:  J R Pfefferkorn; H Löser; G Pech; R Toussaint; F Hilgenberg
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

Review 5.  Isolated unilateral absence of a pulmonary artery: a case report and review of the literature.

Authors:  A Derk Jan Ten Harkel; Nico A Blom; Jaap Ottenkamp
Journal:  Chest       Date:  2002-10       Impact factor: 9.410

6.  Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide.

Authors:  Evangelos Michelakis; Wayne Tymchak; Dale Lien; Linda Webster; Kyoko Hashimoto; Stephen Archer
Journal:  Circulation       Date:  2002-05-21       Impact factor: 29.690

7.  Sildenafil as a treatment for pulmonary hypertension.

Authors:  W D Carroll; R Dhillon
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

8.  Unilateral absence of pulmonary artery and ventricular septal defect in an infant.

Authors:  K Imanaka; S Shimizu; J Matsumoto; K Hashizume; K Tsuchiya; T Takemura
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

9.  Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study.

Authors:  B K S Sastry; C Narasimhan; N Krishna Reddy; B Soma Raju
Journal:  J Am Coll Cardiol       Date:  2004-04-07       Impact factor: 24.094

10.  Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery.

Authors:  Christian Stocker; Daniel J Penny; Christian P Brizard; Andrew D Cochrane; Rodrigo Soto; Lara S Shekerdemian
Journal:  Intensive Care Med       Date:  2003-10-07       Impact factor: 17.440
  10 in total
  2 in total

Review 1.  Sildenafil for the treatment of pulmonary hypertension in pediatric patients.

Authors:  Alice J Huddleston; Chad A Knoderer; Jennifer L Morris; Eric S Ebenroth
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

2.  Rare cardiovascular anomaly: congenital unilateral absence of the pulmonary artery.

Authors:  Bogusław Mazurek; Lesław Szydłowski; Magdalena Mazurek; Joanna Kohut; Jan Głowacki
Journal:  Arch Med Sci       Date:  2013-08-20       Impact factor: 3.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.